BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12536645)

  • 1. [Assessment of dry body-weight in hemodialysis patients by plasma cyclic 3'5'-guanosine monophosphate].
    Xiao XC; Tao LJ
    Hunan Yi Ke Da Xue Xue Bao; 2001 Apr; 26(2):133-5. PubMed ID: 12536645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Living on chronic hemodialysis between dryness and fluid overload.
    Franz M; Pohanka E; Tribl B; Woloszczuk W; Hörl WH
    Kidney Int Suppl; 1997 Jun; 59():S39-42. PubMed ID: 9185103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma cGMP level as a marker of the hydration state in renal replacement therapy.
    Lauster F; Heim JM; Drummer C; Fülle HJ; Gerzer R; Schiffl H
    Kidney Int Suppl; 1993 Jun; 41():S57-9. PubMed ID: 8391608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial dysfunction in patients with kidney failure and vascular risk factors: acute effects of hemodialysis.
    Migliacci R; Falcinelli F; Imperiali P; Floridi A; Nenci GG; Gresele P
    Ital Heart J; 2004 May; 5(5):371-7. PubMed ID: 15185901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment.
    Franz M; Woloszczuk W; Hörl WH
    Kidney Int; 2000 Jul; 58(1):374-83. PubMed ID: 10886584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The postdialytic plasma cyclic guanosine 3':5'-monophosphate level as a measure of fluid overload in chronic hemodialysis.
    Lauster F; Fülle HJ; Gerzer R; Schiffl H
    J Am Soc Nephrol; 1992 Mar; 2(9):1451-4. PubMed ID: 1320949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of dry weight through changes in blood volume and plasma cyclic 3',5'-guanosine monophosphate in patients under maintenance hemodialysis.
    Wann GL; Tsai CS; Lin SH; Huang WD; Chu P; Chen GS; Lin YF
    ASAIO J; 1998; 44(5):M569-73. PubMed ID: 9804497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial natriuretic peptide and cyclic guanosine-monophosphate in children and adolescents on peritoneal dialysis.
    Bald M; Bonzel KE; Rascher W
    Clin Nephrol; 1994 Jul; 42(1):50-3. PubMed ID: 7923967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM; Youssef AM; Zayoon MY
    Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Alteration of homocysteine before and after hemodialysis in chronic hemodialysis patients].
    Wang HT; Peng YM; Liu H
    Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):266-8. PubMed ID: 14653086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioimpedance resistance ratios for the evaluation of dry weight in hemodialysis.
    Spiegel DM; Bashir K; Fisch B
    Clin Nephrol; 2000 Feb; 53(2):108-14. PubMed ID: 10711412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of plasma brain natriuretic peptide detection in cardiac function assessment in hemodialysis patients].
    Shao YH; Lai YQ; Lin AZ; Kong YZ
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jul; 25(7):892-4. PubMed ID: 16027094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between systemic nitric oxide metabolites and cyclic GMP in healthy male volunteers.
    Metzger IF; Sertorio JT; Tanus-Santos JE
    Acta Physiol (Oxf); 2006 Oct; 188(2):123-7. PubMed ID: 16948799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Whole body versus segmental bioimpedance measurements (BIS) of electrical resistance (Re) and extracellular volume (ECV) for assessment of dry weight in end-stage renal patients treated by hemodialysis].
    Załuska W; Małecka T; Mozul S; Ksiazek A
    Przegl Lek; 2004; 61(2):70-3. PubMed ID: 15230144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydration abnormalities in Nigerian patients on chronic hemodialysis.
    Tzamaloukas AH; Onime A; Agaba EI; Vanderjagt DJ; Ma I; Lopez A; Tzamaloukas RA; Glew RH
    Hemodial Int; 2007 Oct; 11 Suppl 3():S22-8. PubMed ID: 17897107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between the cyclic nucleotide content of blood plasma and the clinical course of chronic alcoholism].
    Suchkova SN; Markova MP; Savchenko LM
    Farmakol Toksikol; 1986; 49(4):92-5. PubMed ID: 3019762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple method to estimate phosphorus mobilization in hemodialysis using only predialytic and postdialytic blood samples.
    Agar BU; Akonur A; Cheung AK; Leypoldt JK
    Hemodial Int; 2011 Oct; 15 Suppl 1():S9-S14. PubMed ID: 22093606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Huangdan capsule on plasma cGMP and ANP in rats with chronic renal failure.
    Zheng J; Hong S; Chen S; Chen J; Zhang C
    J Tongji Med Univ; 1998; 18(2):75-7. PubMed ID: 10806828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of sodium profiling on blood volume and intradialytic hypotension in patients on maintenance hemodialysis.
    Kaczmarczyk I; Kraśniak A; Drozdz M; Chowaniec E; Gajda M; Radziszewski A; Sułowicz W
    Przegl Lek; 2007; 64(7-8):476-82. PubMed ID: 18409348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypertension in hemodialysis patients in Andalucia].
    García Cortés MJ; Ceballos M;
    Nefrologia; 2004; 24(2):149-57. PubMed ID: 15219090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.